neutralize
发表于 2025-3-30 11:33:05
http://reply.papertrans.cn/19/1884/188318/188318_51.png
Transfusion
发表于 2025-3-30 14:00:29
Stabilisation of biopharmaceutical products and finished product formulations,m a clinical and regulatory point of view. Furthermore, the stability profile should cover the manufacturing and marketing cycles of the product to minimise costs. The major routes by which proteins may be degraded are outlined. A brief description of biopharmaceutical production processes is provid
键琴
发表于 2025-3-30 19:01:24
Patent Law for Biopharmaceuticals,stry, and biotechnology in all their many sub-categories. To be patentable, biopharmaceuticals and their processes of manufacture have to meet the same three legal tests of novelty, inventiveness, and practical utility as do the simpler compounds and preparative methods of synthetic chemistry. As fo
FIR
发表于 2025-3-30 21:12:47
http://reply.papertrans.cn/19/1884/188318/188318_54.png
宿醉
发表于 2025-3-31 01:02:16
http://reply.papertrans.cn/19/1884/188318/188318_55.png
脾气暴躁的人
发表于 2025-3-31 06:24:40
http://reply.papertrans.cn/19/1884/188318/188318_56.png
残酷的地方
发表于 2025-3-31 09:54:24
Marketing Issues for the (Bio)pharmaceutical sector, use. It is often fruitless and costly to begin developing marketing programs and spending money in advance of making careful and global strategic assessment. This chapter focusses on this and related issues central to the successful marketing of (bio)pharmaceutical products.
ANTIC
发表于 2025-3-31 15:48:19
http://reply.papertrans.cn/19/1884/188318/188318_58.png
删除
发表于 2025-3-31 17:50:26
lsorenders it an ideal reference source for students undertaking advancedundergraduate or postgraduate courses in biotechnology, pharmaceuticalscience, biochemistry or medicine.978-90-481-5237-7978-94-017-0926-2
Corral
发表于 2025-4-1 00:00:46
http://reply.papertrans.cn/19/1884/188318/188318_60.png